Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Solesence (SLSN) Cash & Equivalents (2016 - 2026)

Solesence filings provide 17 years of Cash & Equivalents readings, the most recent being $573000.0 for Q1 2026.

  • On a quarterly basis, Cash & Equivalents fell 68.46% to $573000.0 in Q1 2026 year-over-year; TTM through Mar 2026 was $573000.0, a 68.46% decrease, with the full-year FY2025 number at $1.3 million, down 8.59% from a year prior.
  • Cash & Equivalents hit $573000.0 in Q1 2026 for Solesence, down from $1.3 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $4.1 million in Q2 2025 to a low of $429000.0 in Q3 2025.
  • Median Cash & Equivalents over the past 5 years was $1.4 million (2024), compared with a mean of $1.6 million.
  • Biggest five-year swings in Cash & Equivalents: surged 232.72% in 2022 and later crashed 85.33% in 2025.
  • Solesence's Cash & Equivalents stood at $2.2 million in 2022, then dropped by 21.23% to $1.7 million in 2023, then fell by 18.18% to $1.4 million in 2024, then dropped by 8.59% to $1.3 million in 2025, then crashed by 55.51% to $573000.0 in 2026.
  • The last three reported values for Cash & Equivalents were $573000.0 (Q1 2026), $1.3 million (Q4 2025), and $429000.0 (Q3 2025) per Business Quant data.